NEW YORK, Jan. 29, 2016 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Identiv, Inc. securities (NASDAQ:INVE) from November 7, 2013 through November 23, 2015, all dates inclusive (the “Class Period”) of the important February 5, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Identiv investors under the federal securities laws.
To join the Identiv class action, go to the firm’s website at http://rosenlegal.com/cases-795.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll free at 866-767-3653 or email [email protected] or [email protected] for more information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE
According to the lawsuit, throughout the Class Period, defendants issued false and misleading statements to investors and/or failed to disclose that: (1) Identiv had engaged in inappropriate revenue recognition practices; (2) Identiv’s senior management encouraged a closed and ineffective control environment; (3) Identiv’s key accounting metrics were misstated; (4) Identiv lacked adequate internal controls at all relevant times; and (5) as a result, defendants’ statements about Identiv’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 5, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://rosenlegal.com/cases-795.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Shell M&A Chief Exits After BP Takeover Proposal Rejected
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 



